Last spring, published research suggested angiotensin receptor blockers could lower the risk for ventilation and vasopressors in men with COVID-19. Just this week, however, an article released by the Journal of the American Medical Association noted that ARBs do not improve outcomes in patients hospitalized with COVID-19. The trial included 787 patients at 17 hospitals in Australia and India and covered the period from May 2020 to November 2021. The vast majority of patients (n=778), …
Read More![New Data Present a Different View of How Helpful ARB’s Are—or Aren’t—with COVID New Data Present a Different View of How Helpful ARB’s Are—or Aren’t—with COVID](https://www.jucm.com/wp-content/uploads/2022/12/New-Data-Present-a-Different-View-image-750x350.jpeg)